It's early in 2025 and already, there are a huge deal of upcoming Xbox Series X games on the way. February will see a slew of new games land on the platform and Game Pass, with Obsidian's own RPG ...

If you want to keep your tower standing, it’s a good idea to use our Tower Defense X codes guide. Here, you can get all the gold you need to build your defenses. As the name implies, this Roblox ...

While having long battery life is one of the most important aspects of a phone, it is also important to know that you can quickly recharge it when the need arises. Given that many of us use their ...

It is the largest study ever of the drug category—which includes Novo Nordisk’s GLP-1 treatments Ozempic and Wegovy and Eli Lilly’s dual-action GLP-1/GIP agonists Mounjaro and Zepbound.

Elon Musk's social media platform, X, has introduced a dedicated video tab that lets you watch video content in a reel format. This announcement comes as ByteDance-owned TikTok restores its ...

X has launched a new video tab for US users after TikTok was banned. Industry analysts estimate this strategic move could help X capture a significant portion of TikTok’s 170 million US user ...

With nearly $14 billion in sales in 2023, it shows no signs of slowing down, much to the delight of its Danish manufacturer, Novo Nordisk A/S (NYSE: NVO). A Scandinavian economic behemoth ...

The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be targeted under legislation that’s expected save the government more than ...

Lone Star Funds is selecting advisers to explore a possible sale or initial public offering of Portuguese lender Novo Banco SA, according to people familiar with the matter. The private equity ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is rolling out new data on a higher-dose injection in obesity. In the phase 3b ...

Medicare’s next drug price negotiations will treat Novo Nordisk’s semaglutide as a single product, regardless of whether the metabolic disease medicine is used to treat diabetes or heart risk, and ...